SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer drug tested in patients with autoimmune conditions
Disease control Recruiting nowThis study is testing the safety of the immunotherapy drug nivolumab in people who have both advanced cancer and an autoimmune disease like lupus, rheumatoid arthritis, or Crohn's disease. It will enroll 300 adults to see how well they tolerate the treatment and to find the right…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Radiation and transplant tested as potential reset for severe autoimmune disease
Disease control Recruiting nowThis early study is testing a new way to prepare patients for a stem cell transplant to treat severe scleroderma. Doctors want to see if using a more precise form of total body radiation, along with chemotherapy, is safe and feasible before the transplant. The goal is to 'reset' …
Matched conditions: SYSTEMIC SCLERODERMA
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Light test could replace pinch exam for scleroderma skin
Diagnosis Recruiting nowThis study is testing a new, painless imaging device that uses light to measure skin thickening in people with scleroderma. Researchers want to see if this method is more accurate and consistent than the current standard, where doctors pinch the skin to assess thickness. The stud…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Boston University • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
Scientists hunt clues in rare Family-Linked scleroderma
Knowledge-focused Recruiting nowThis study aims to learn more about systemic scleroderma, a rare autoimmune disease, by studying families where more than one member has it. Researchers will recruit 20 adults with the disease who also have a close relative with it. By comparing these 'familial' cases, they hope …
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC